, APAC
Photo from Envato

Chronic obstructive pulmonary disease market to hit $30.8b by 2033

Its growth is attributed to the introduction of new treatments.

The chronic obstructive pulmonary disease (COPD) market is projected to reach $30.8b by 2033 across the seven major markets, namely the US, France, Germany, Italy, Spain, the UK, and Japan, said GlobalData.

The expansion is attributed to the introduction of new treatments, including the first biologic for COPD, Sanofi and Regeneron’s Dupixent (dupilumab), and other therapies currently in development.

Meanwhile, inhaled corticosteroids, long-acting beta-2 agonists, and long-acting muscarinic antagonists will remain the dominant treatment modality for the disease.

 “The entry of these newer therapies will be used as add-on maintenance treatment for COPD patients, supplementing the SOC,” Asiyah Nawab, Pharma Analyst at GlobalData, said.

“While the COPD market is projected to grow strongly in the forecast period, potential barriers to this growth include loss of exclusivity within the forecast period,” Nawab added.

 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.